Antibody (or protein) Drug Conjugates (ADCs)

A unique perspective on the total synthesis of a biomolecule conjugate

We bring together the important knowledge of the science of organic chemistry development for small molecules and the technical expertise of peptide synthesis and post-synthesis modification and conjugation.  This is our unique way of developing and manufacturing an Antibody-Drug Conjugate.

Analytical requirements draw from techniques used for both small molecule and large molecules. We have independently developed expertise in both areas and can efficiently develop and validate required methods in-house.

Our small molecule teams are not intimidated by and do not have bias in the handling and purification techniques required for a large molecule. We’ve created an expert team from both the ‘large molecule’ and ‘small molecule’ groups, to implement an ADC project that ensures all challenges are anticipated and met.

Related Resources